Bristol-Myers Squibb Company (BMY) forecast
Bristol-Myers Squibb Company (BMY) forecast: price $63.08, trailing P/E 13.46, forward P/E 9.98. How to read the street's path.
The live BMY price is $63.08. Trailing P/E is 13.46 and forward P/E is 9.98. The forecast that matters is the earnings path those ratios imply, not a single target price.
A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.
Use this page for the BMY forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.
Learn: Forward P/E · Analyst forecast · DCF
Full BMY quote · Dividends · Price prediction · Academy
Questions
What is BMY's forward P/E?
The latest forward P/E on Stocklytics is 9.98, against a trailing P/E of 13.46 and a price of $63.08.
Is the analyst target the forecast?
It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.